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a b s t r a c t
With telehealth services rescuing patients with chronic neurological disorders during the COVID-19 pan-
demic, there is a need for simplified teleneurology protocols for neurological disorders in children.
Infantile spasms is an epileptic encephalopathy where treatment lag is a significant predictor of outcome.
It is one such condition where telemedicine can make a remarkable difference when in-person consulta-
tions are delayed or are not possible. However, the adverse effect profile of the first-line therapeutic
options, the need for frequent follow-up, underdeveloped telemedicine services, lack of a rational proto-
col, poor awareness about infantile spasms, a lesser level of parental understanding, and scarcity of pedi-
atric neurologists are the major hurdles in developing countries. This paper provides a teleneurology
based approach for the management of infantile spasms in developing countries during the COVID-19
pandemic. The cornerstones of this approach include the fundamental principles of management of
infantile spasms, decentralization of patient care to local health providers, efforts for improving sensitiv-
ity and specificity of diagnosis, early initiation of first-line therapeutic options, and constant motivation
of parents and local health providers to be vigilant for therapeutic response, adverse effects of therapy,
and infections.
 2021 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The coronavirus disease-2019 (COVID-19) pandemic has signif-
icantly impacted the customary delivery of healthcare. Although
children mostly remain asymptomatic, infants are particularly sus-
ceptible [1]. Negative consequences due to nationwide lockdowns,
travel restrictions, and fear among patient families have affected
the care of children with epilepsy like Infantile spasms (IS; includ-
ing West syndrome) [2]. Young age, comorbidities, need for hor-
monal therapy, and frequent healthcare visits are problems
specific to children with IS [3]. Although the exact numbers are
not known, the burden of IS and the treatment gap in developing
countries is expected to be high considering the rampant causes
of acquired brain injury such as hypoxic-ischemic brain injury,
infections, etc., and relatively underdeveloped health infrastruc-
ture. Their management challenges are also distinct, e.g., a prepon-
derance of structural etiology, significant lead-time-to-treatment,
limited access to pediatric neurologists and specific investigations
including electroencephalography (EEG), and problems with
availability and licensing of first-line drugs [adrenocorticotrophic
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hormone (ACTH) and vigabatrin] [4,5]. Moreover, the probable
escalation of treatment lag (a significant predictor of outcome)
due to prevalent travel restrictions is expected to adversely affect
the outcome in children with IS [6]. Hence, the management pro-
tocols of the developed countries may not be entirely applicable
to the developing nations.
Teleneurology is a well-established tool for epilepsy manage-
ment, especially when face-to-face consultations are difficult
(e.g., pandemic involving difficult access to care) [7]. In developing
countries, the use of teleneurology is even more desirable during
the COVID-19 pandemic to decentralize the patient care to com-
munity health services, promote healthcare access, reduce treat-
ment lag, and cost of care [8]. However, considering the adverse
effects associated with first-line therapeutic options for IS, reduced
facilities, and lesser level of parental understanding in developing
countries, a higher degree of vigilance is required during telecon-
sultations for IS. Therefore, a need for a simplified protocol for
the management of IS via teleneurology exists.
2. Methods
The South Asia Allied West Syndrome Research Group devel-
oped an algorithm for teleneurology-based care of children with
IS in developing countries. The initial research group had evaluated
the management practices for West syndrome in South Asia and
subsequently, developed a viewpoint statement on the manage-
ment concerns during the COVID-19 pandemic [4,9]. The current
study group initially searched the PubMed and EMBASE using the
search terms ‘‘Infantile spasms OR West syndrome AND Teleneu-
rology AND/OR COVID-19” until June 30, 2020, and later updated
the literature review until September 20, 2020. The recommenda-
tions and guidelines developed by other societies/research groups
were also searched.
Since the literature search did not reveal any specific recom-
mendations or original research on teleneurology specific to IS
during the COVID-19 pandemic, a simplified algorithmic
teleneurology-based approach is being proposed keeping the gen-
eral recommendations by the Child Neurology Society (CNS) and
our group as the basis [3,9]. These recommendations and the con-
cerns raised by the group members were discussed through multi-
ple correspondences. The initial draft was formulated and revised
on Google docs by authors based on the available evidence, exper-
tise, practicality in their countries, and consensus. The concerns
raised by group members in the algorithm were discussed and
addressed through multiple emails and modifications were made
in the algorithm based on suggestions.
3. Discussion and proposed approach
Fig. 1 illustrates a proposed simplified algorithm for teleconsul-
tations for the management of IS.
3.1. Telemedicine tools
Despite the lack of organized telehealth facilities, there is easy
access to smartphones in developing countries [7]. Tools with
video modes of communication such as video-calls on a chat plat-
form, Skype, video conferencing solutions, etc. may be the pre-
ferred options [7,9]. Unlike the USA, the South Asian and many
developing countries don’t follow Health Insurance Portability
and Accountability (HIPAA) standards. However, country-specific
recommendations for telemedicine need to be practiced. Patient
confidentiality is of prime importance. WhatsApp, an end-to-end
encrypted chat platform, may be useful in many developing coun-
tries since it ensures that the patient data is not available with any
private company. Hence, such tools may be used for interaction,
sharing of patient videos, and providing prescriptions.
Some legal safeguards which may be helpful in the context of IS
include proper documentation and recording of the consultation after
parental consent, running a checklist of signs (including critical
events) suggesting a need for an in-person consult before the begin-
ning of teleconsult, maintaining a record of prescriptions, etc. Specific
safeguards in each country also need to be considered [8,10].
3.2. First evaluation
At the first evaluation, video-teleconsultation or in-person consul-
tation is preferred depending on travel restrictions and COVID-19
transmission in the region. Teleconsultation with the managing pedi-
atrician or pediatric neurologist should be in liaison with a local
health provider involved in the patient care. Each new consult should
begin with general information (relevant history including clinical,
family, past medical, perinatal, developmental, and treatment history;
and focused physical/neurological examination). Detailed information
on spasms, e.g., age at onset, clustering, type, relation with the sleep-
wake cycle, burden, should be sought. Assessment of home videos of
habitual events is strongly encouraged. Efforts should be made to
determine the etiology [history of prior brain insult e.g., neonatal
asphyxia, hypoglycemia, infections, or trauma; the presence of neuro-
cutaneous abnormalities like ash-leaf spots (tuberous sclerosis com-
plex), etc.]. Comorbidities should be looked for carefully. Besides a
pretreatment screen to rule out any infections including tuberculosis,
baseline parameters such as weight and blood pressure (BP) should be
recorded. Baseline urine and blood sugar, electrolytes, liver enzymes,
complete blood count, etc. should be recorded if possible.
3.3. Electroencephalogram
In agreement with the CNS recommendations, outpatient EEG
comprising at least one sleep-wake cycle is advisable for confirma-
tion of diagnosis, but treatment initiation should not be delayed if
EEG is not feasible [3]. EEG should preferably be done at a place with
expertise for hypsarrhythmia reporting. If conducted regionally, the
technician and reporting person should be well-informed about the
expectations from the report. Application of objective scoring for
hypsarrhythmiamay be considered based on feasibility and availabil-
ity of expertise. Various available scores are Burden of Amplitudes
and Epileptiform Discharges (BASED), score by Kramer and col-
leagues, score by Jeavons and Bower, etc. [11–13]. BASED score
appears simple, feasible, and reliable tool with a favorable inter-
rater agreement [11]. EEG confirmation of hypsarrhythmia would
be useful for the initial diagnosis and the subsequent decision-
making. However, it is important to note that hypsarrhythmia is
not always present and is not essential to diagnose IS [14]. Availabil-
ity of EEG and Magnetic Resonance Imaging (MRI) facilities is also a
major limitation in many developing countries. Creation of this
infrastructure will require funds and may not be possible acutely
during this hour of crisis. Hence, gradual but persistent efforts
towards creating a framework for the widespread availability of
these investigations may be helpful.
3.4. Efforts to improve sensitivity and specificity of diagnosis and
reduce treatment lag
In addition to objective EEG scoring, awareness regarding the
semiology and development and validation of an objective clinical
scoring system based on history and event videos may be benefi-
cial. Also, easy access to this objective score in a smartphone appli-
cation may ease the diagnostic process for local health providers
and pediatricians. Furthermore, training of local health care
providers and pediatricians through webinars for diagnosis and
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management of IS will also be advantageous. Establishing a linkage
facility for paediatricians to reconfirm their observations and
management decisions with Paediatric neurologists may also be
helpful. Besides, creating awareness among parents through mass
media (screening children with neonatal brain injury during visits
for immunization) will probably reduce the treatment lag.
3.5. Initial treatment advice
The initial choice should be one of the standard first-line med-
ications: ACTH, prednisolone, and vigabatrin. Contraindications for
high-dose hormonal therapy include acute infections, a history of
clinical infection caused by herpes or cytomegalovirus, and
Fig. 1. Algorithm for teleneurology-based care of children with Infantile spasms in developing countries during the COVID-19 pandemic.
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congestive heart failure. In accord with the CNS recommendations,
high-dose oral prednisolone may be the preferred initial therapy
during the COVID-19 pandemic [3] Preferably syrups/ suspensions
should be prescribed, and printed advice regarding dispensing and
administration of liquid formulation using a syringe and possible
adverse effects of medications and danger signs should be pro-
vided. Caregivers should be advised to record the daily burden of
spasms, change in seizure types, and adverse effects of atniseizure
medications (e.g. irritability, sleep disturbances, any new-onset
symptoms of infections like fever, cough, respiratory distress,
etc.). There is a risk of hypertension with hormonal therapy requir-
ing BP monitoring [3,15]. Availability of appropriate-sized BP cuff
for infants is an issue. Further, BP monitoring at home is challeng-
ing, hence may be done at a nearby healthcare facility. Urine sugar
may be monitored at home. Besides, repeated emphasis should be
given on general precautions such as the use of masks, social dis-
tancing, and hand hygiene.
3.6. Follow-up
The first follow-up should be scheduled after a week (or earlier
depending on clinical need) of treatment initiation for assessing
compliance, tolerability, and response to therapy. The next tele-
consultation should be at two weeks of therapy. EEG is desirable
to demonstrate resolution of hypsarrhythmia at this point, how-
ever, the feasibility and access may be issues. Depending on the
therapeutic response, the initial therapy may be continued or
switched to or supplemented with another first-line drug. Subse-
quent follow-up should be scheduled once in two weeks for assess-
ment of therapeutic response, drug compliance, adverse effects,
and need for modification of therapy. All the available first-line
options need to be exhausted before going to second-line thera-
pies. It is important to reiterate that teleconsultation should be
switched to in-person consultation in the event of a diagnostic or
management uncertainty.
4. Conclusion
Despite the innumerable pros of teleneurology, there are some
limitations such as lack of detailed examination, limited access to
investigations, problems with infrastructure and internet facilities,
confidentiality, and legal implications involved. However, it seems
to be a simple and convenient tool during the COVID-19 pandemic
to provide optimal care while minimizing hospital visits. Although
formal evaluation of the effectiveness of this approach is evolving,
the advantages of early diagnosis and reduction in treatment lag
are presumed to outweigh this limitation. Future studies should
be done to validate this approach and algorithm in developing
countries.
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